Epi6: Modernizing Tissue Prep: Why Manual Front Ends Hold Labs Back

Connect with Gabby: https://www.linkedin.com/in/gabriella-ryan-m-s-9519a1139/ Connect with Bill: https://www.linkedin.com/in/founderandcdo/Check out Gabby's LinkedIn Newsletter: Precision Prep, Research Ready: https://www.linkedin.com/newsletters/precision-prep-research-ready-7303865151785480192/ Labs invest heavily in downstream instruments—but if tissue prep is still manual, that front-end bottleneck can quietly undermine the entire workflow. Too often, labs are trying to do 2026 science with 2016 tech.In this episode of Omni Pod, I, Bill Schick (Fractional CMO @ meshagency.com), sit down with Gabby Ryan, Sr. Application Scientist at Omni International, a Revvity brand, to talk about why expensive instruments struggle when the front end is manual—and how automating tissue prep brings consistency, protects data, and gives labs the reliability they need as workflows scale.See how Omni supports consistent, semi-automated tissue prep with the Bead Ruptor Elite:https://www.revvity.com/category/bead-mill-homogenizersAnd how high-throughput labs automate homogenization with the LH 96 platform:https://www.revvity.com/category/automated-homogenizersWe dig into what Gabby sees every day in the field: labs running advanced sequencing, biomarker, and drug-development workflows on the back end while still relying on rotor-stators, mortar and pestle methods, or aging bead mills on the front end. She explains how manual prep creates fatigue, variability, cross-contamination risk, rework, and QC failures—and why labs often do not realize sample prep is the problem until scale makes the bottleneck impossible to ignore.What you’ll learn:Why manual tissue prep becomes a liability as labs scale from dozens of samples to hundreds or thousandsHow front-end inconsistency can show up as failed QC, poor DNA/RNA/protein quality, reruns, and questionable downstream dataWhat operator fatigue, probe cleaning, and manual sample handling can introduce into a workflowWhy expensive downstream platforms cannot compensate for weak or inconsistent sample lysis upstreamHow semi-automated bead milling helps labs process samples the same way every timeWhen it makes sense to move from manual methods to semi-automated or fully automated homogenizationHow labs can redeploy skilled scientists away from repetitive sample grinding and toward higher-value workWhy automation at the front end is increasingly necessary for modern drug development and high-throughput researchWho this is for:Lab managers, application scientists, translational and preclinical research teams, and anyone running tissue prep ahead of extraction, sequencing, or other downstream analysis—especially if your back-end workflow is advanced but your front-end process is still largely manual.Subscribe for more practical, lab-tested conversations on building faster, cleaner, and more repeatable workflows at the front end of preclinical research—and drop your sample-prep questions in the comments so we can tackle them in a future